Nephrogen
PrivateLast Round
Pre Seed
Nov 28, 2025
Est. Valuation
$1.79M
Total Funding Raised
$2.65M
Company Overview
Nephrogen is a biotechnology company that develops curative gene and genomic therapies for kidney and pancreatic conditions using its proprietary AI-driven NeFIND™ platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nephrogen Comparables
Compare Nephrogen with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nionyx Bio | 88% | |
| Shape Therapeutics | 78% | |
| Silver Spur Therapeutics | 77% | |
Nephrogen Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | Nov 28, 2025 | ||||
| Seed | Oct 27, 2025 | ||||
| Grant | Nov 15, 2024 | ||||
| Grant | Jul 13, 2023 | ||||
| Accelerator | Aug 31, 2020 | ||||
Accelerator | Jun 1, 2020 |
Nephrogen Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| StartX | Accelerator |
| Empire State Development | Grant |
| ZAKA VC | Pre Seed |
| 2048 Ventures | Grant |
| Y Combinator | Accelerator |
| National Institutes of Health (NIH) | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 27, 2025
Attending TechCrunch Disrupt 2025 to showcase AI and gene therapy technology.
Nephrogen Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Nephrogen's valuation, stock price, and market status.